Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apollo Global Management | APO | Sep 19, 2024 | 121.62 | +3.46 |
Apollomics A | APLM | Sep 19, 2024 | 0.13 | +3.22 |
AppFolio A | APPF | Sep 19, 2024 | 231.82 | +1.19 |
Appian A | APPN | Sep 19, 2024 | 33.75 | +1.81 |
Apple | AAPL | Sep 19, 2024 | 228.87 | +3.71 |
Apple Hospitality REIT | APLE | Sep 19, 2024 | 15.18 | +4.98 |
Applied Digital | APLD | Sep 19, 2024 | 5.56 | -8.40 |
Applied DNA Sciences | APDN | Sep 19, 2024 | 1.21 | -8.33 |
Applied Industrial Technologies | AIT | Sep 19, 2024 | 224.05 | +4.27 |
Applied Materials | AMAT | Sep 19, 2024 | 196.71 | +5.68 |
Applied Optoelectronics | AAOI | Sep 19, 2024 | 14.20 | +6.93 |
Applied Therapeutics | APLT | Sep 19, 2024 | 8.00 | +1.91 |
Applovin A | APP | Sep 19, 2024 | 124.00 | +0.68 |
AppTech Payments | APCX | Sep 19, 2024 | 0.74 | -2.75 |
Aprea Therapeutics | APRE | Sep 19, 2024 | 2.92 | +2.10 |
AptarGroup | ATR | Sep 19, 2024 | 156.90 | +2.50 |
Aptevo Therapeutics | APVO | Sep 19, 2024 | 0.18 | +6.93 |
Aptiv | APTV | Sep 19, 2024 | 70.52 | +1.22 |
Aptorum Group A | APM | Sep 19, 2024 | 2.24 | +0.90 |
Aptose Biosciences | APTO | Sep 19, 2024 | 0.40 | -1.96 |
APx Acquisition I A | APXI | Sep 19, 2024 | 11.64 | 0.00 |
APx Acquisition I Unit | APXIU | Sep 19, 2024 | 11.66 | 0.00 |
Apyx Medical | APYX | Sep 19, 2024 | 1.09 | +3.81 |
Aqua Metals | AQMS | Sep 19, 2024 | 0.19 | -4.37 |
AquaBounty Technologies | AQB | Sep 19, 2024 | 1.28 | +6.67 |
Aquaron Acquisition | AQU | Sep 19, 2024 | 11.00 | 0.00 |
Aquaron Acquisition Units | AQUNU | Sep 19, 2024 | 11.01 | 0.00 |
Aquestive Therapeutics | AQST | Sep 19, 2024 | 5.20 | +5.05 |
Aramark | ARMK | Sep 19, 2024 | 38.91 | +2.18 |
ARB IOT Group | ARBB | Sep 19, 2024 | 0.26 | -2.84 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.